Longitudinal cohort study finds Prevotella stercorea lowers infection risk in children, indicating potential protective mechanisms.
Using a longitudinal cohort of 633 Gambian children (IHAT-GUT, NCT02941081), we investigated two ecologically distinct pathways potentially linking Prevotella stercorea abundance to infection risk: a community-mediated pathway operating through overall gut microbiome richness, and a species-specific pathway operating independently of it. We modelled P. stercorea abundance in relation to gut microbiome richness, adverse-event incidence (diarrhoea, acute respiratory infection [ARI], fever), inflammatory biomarkers (CRP, AGP; measured at enrolment [D1] only), and weight-for-age z-score (WAZ), using richness-mediation analysis, negative binomial and joint-species models, and WAZ-stratified interaction models, with Benjamini–Hochberg correction applied within each family of related tests. P. stercorea abundance positively predicted gut microbiome richness, consistent with a role in community-level colonisation resistance for enteric outcomes. Its association with reduced ARI persisted largely unchanged after richness adjustment, consistent with a richness-independent, species-autonomous pathway. WAZ was uncorrelated with microbiome richness within strata, consistent with WAZ serving as a proxy for host immune-metabolic reserve rather than a determinant of microbiome composition. In Low-WAZ children, P. stercorea abundance at Day 1 was associated with suppressed CRP; in High-WAZ children, elevated Day 1 inflammation predicted subsequent P. stercorea abundance at Day 85. ARI and fever protection was richness-independent and concentrated in Low-WAZ children (q≤ 0.006); P. copri did not retain an independent protective association when modelled jointly with P. stercorea (q = 0.381 vs. q = 0.016). These findings are consistent with a richness-independent, host-context-dependent association between P. stercorea abundance and respiratory infection risk. Given the observational design, causal and mechanistic interpretations remain hypothesis-generating; experimental validation and independent replication are needed before translational application can be considered.
No takes yet. Share an insight, caveat, or question.
Ogochukwu Ofordile (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: